Jan 5, 2026 · A biosimilar is not considered a “generic” in the same way that a traditional, small molecule drug (for example: ibuprofen or acetaminophen) is determined to be a generic. …

Dec 19, 2025 · Is there a list of all biosimilars approved in the United States? There have been 81 biosimilars approved by the U.S. Food and Drug Administration (FDA). The most recent …

Oct 10, 2025 · An interchangeable biosimilar is a biologic product that can be automatically substituted for the reference product (in this case, Eylea) by your pharmacist, depending upon …

The FDA approval of Kirsty expands Biocon Biologics’ biosimilar insulin portfolio, which also includes the first approved interchangeable biosimilar, Semglee® (Insulin Glargine-yfgn …

Jun 3, 2025 · Yesintek is an interchangeable biosimilar to Stelara used to treat plaque psoriasis, active psoriatic arthritis, or moderately to severely active Crohn's disease or ulcerative colitis in …

Jun 3, 2025 · Otulfi is an interchangeable biosimilar to Stelara used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis, which are …

Apr 2, 2025 · Zarxio (filgrastim-sndz) is biosimilar product used to treat neutropenia associated with chemotherapy. Includes Zarxio side effects, interactions and indications.

May 2, 2025 · Ruxience is a biosimilar to Rituxan and is used to treat certain leukemias and lymphomas and some non-cancer conditions, such as rheumatoid arthritis and polyangiitis. It …

Jun 4, 2025 · Amjevita is an interchangeable biosimilar to Humira used to treat rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, …

Jun 24, 2025 · Steqeyma is an interchangeable biosimilar to Stelara used to treat Crohn's disease, ulcerative colitis, moderate to severe plaque psoriasis, and active psoriatic arthritis.